Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
BMC Medical Genetics|December 19, 2012
Genotype-phenotype correlation in 22q11.2 deletion syndromeElena Michaelovsky, Amos Frisch, Miri Carmel, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 30, 2010
Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center studyGil Zalsman, Miriam Patya, Amos Frisch, et al.The International Journal of Neuropsychopharmacology|October 24, 2007
Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DSElena Michaelovsky, Doron Gothelf, Michael Korostishevsky, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2016
Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disordersMaya Amitai, Sefi Kronenberg, Miri Carmel, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 24, 2009
Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label studyShella Schirman, Sefi Kronenberg, Alan Apter, et al.Journal of the American Academy of Child and Adolescent Psychiatry|October 26, 2013
Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site studyDoron Gothelf, Maude Schneider, Tamar Green, et al.Journal of Child and Adolescent Psychopharmacology|March 5, 2008
Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disordersSefi Kronenberg, Alan Apter, David Brent, et al.American Journal of Medical Genetics|February 13, 2002
Association of tetralogy of Fallot with a distinct region of del22q11.2Gania Kessler-Icekson, Einat Birk, Ari Y Weintraub, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic studyGil Zalsman, Amos Frisch, Shaul Lev-Ran, et al.Journal of Psychiatric Research|August 6, 2013
Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypesOmer Zarchi, Miri Carmel, Chen Avni, et al.Pageof 6